Global News

Center for Biomedical Research, Ackerman Cancer Center partner on clinical registry

Friday, May 22, 2015 01:47 PM

The Center for Biomedical Research (CBR) is partnering with Ackerman Cancer Center, a new proton therapy center, as part of a clinical meta-registry for clinical outcomes and long-term follow-up of cancer patients receiving proton therapy.

More... »

Quest Diagnostics

Eureka Therapeutics, Boehringer Ingelheim collaborate on cancer treatments

Friday, May 22, 2015 01:42 PM

California-based Eureka Therapeutics and Germany-based Boehringer Ingelheim have entered into a research agreement for the discovery of novel therapeutic antibodies in oncology.

More... »

York U Researchers to look for patterns in patient data from ManagingLife's pain diary app

Thursday, May 21, 2015 02:51 PM

A digital journal of pain occurrences maintained by the users of an innovative app, Manage My Pain, will be the key source for their upcoming study, said York University psychology researchers. The app's developer ManagingLife, a privately held mobile tool developer based in Toronto, Canada, will provide the large database to York U in a collaborative effort.

More... »

PatientsLikeMe appoints Jason Johnson executive vice president and head of R&D

Thursday, May 21, 2015 02:46 PM

PatientsLikeMe has appointed Jason Johnson, Ph.D., as executive vice president and head of R&D. Johnson leads the company's research, data science and informatics teams, which focus on analyzing and merging patient-reported and other data types to develop models of disease progression and generate new insights about disease, treatments and health. Johnson reports directly to CEO Martin Coulter.

More... »

BioNTech, Genmab ink immuno-oncology agreement

Thursday, May 21, 2015 02:11 PM

BioNTech, a German-based fully integrated biotechnology company developing personalized cancer immunotherapies, has signed an agreement with Genmab, a publicly traded international biotechnology company, to jointly research, develop and commercialize multiple bispecific antibodies for cancer immunotherapy using proprietary technologies from both companies: BioNTech’s proprietary immunomodulatory antibodies and Genmab’s DuoBody technology platform.

More... »

BioClinica, Kinapse partner to accelerate risk-based monitoring implementation

Thursday, May 21, 2015 02:04 PM

BioClinica, a specialty clinical trials services and technology provider, has partnered with Kinapse, a global provider of outsourcing services to life sciences organizations, suppliers and regulators, to accelerate Risk-Based Monitoring (RBM) implementation on global clinical trials using BioClinica's Compass Intelligent Monitoring solution.

More... »

Baxter, Baxalta highlight business strategies

Thursday, May 21, 2015 07:36 AM

In advance of the July 1 spin-off of Baxalta from Baxter International, executives from the companies have shared their vision, strategies and initiatives underway to drive product innovation and accelerated growth over the long-term. Each company has provided updates on its financial outlook, new product pipeline and growth prospects.

More... »

Verified Clinical Trials, Integreview IRB create new expedited research subject authorization review process

Thursday, May 21, 2015 07:35 AM

Verified Clinical Trials (VCT) and Integreview IRB have developed a preferred partnership to stop dual enrollment in clinical trials and reduce protocol deviations while promoting safety. Research sites, CROs and pharmaceutical sponsors will benefit from this alliance in an effort to stop dual enrollment in clinical trials and reduce significant protocol violations from occurring. 

More... »

Banook-CardiaBase Group’s subsidiaries consolidate under name of parent company

Wednesday, May 20, 2015 03:21 PM

Banook Group, an international provider of cardiac safety, central imaging and endpoint adjudication services, will combine its three subsidiaries into one unique name and brand. To accompany the rebrand, Banook Group has introduced a new logo and launched a new website,

More... »

WCG, Certara co-sponsor Lasker Lessons in Leadership events

Wednesday, May 20, 2015 03:20 PM

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services and software to support clinical research, and Certara, a global biosimulation technology-enabled drug development consultancy, are co-sponsoring the inaugural Lasker Lessons in Leadership, a series of one-day career-oriented workshops for postgraduate medical research students. This program, which has been developed by the Albert and Mary Lasker Foundation in collaboration with the International Biomedical Research Alliance and the NIH Oxford-Cambridge Scholars Program, began May 19 at the NIH Main Campus in Bethesda, Md.

More... »



May 26

inVentiv Health aims to help sponsors prepare for new E.U. regulations on observational studies

ACRP partners with CRO Analytics to measure investigative sites' views of clinical trial quality

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs